Cell Cycle Regulation by Alternative Polyadenylation of CCND1

被引:0
|
作者
Qiong Wang
Guopei He
Mengmeng Hou
Liutao Chen
Shangwu Chen
Anlong Xu
Yonggui Fu
机构
[1] Guangdong Province Key Laboratory of Pharmaceutical Functional Genes,State Key Laboratory for Biocontrol
[2] Department of Biochemistry,undefined
[3] School of Life Sciences,undefined
[4] Sun Yat-sen University,undefined
[5] Higher Education Mega Center,undefined
[6] Beijing University of Chinese Medicine,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Global shortening of 3′UTRs by alternative polyadenylation (APA) has been observed in cancer cells. However, the role of APA in cancer remains unknown. CCND1 is a proto-oncogene that regulates progression through the G1-S phase of the cell cycle; moreover, it has been observed to be switching to proximal APA sites in cancer cells. To investigate the biological function of the APA of CCND1, we edited the weak poly(A) signal (PAS) of the proximal APA site to a canonical PAS using the CRISPR/Cas9 method, which can force the cells to use a proximal APA site. Cell cycle profiling and proliferation assays revealed that the proximal APA sites of CCND1 accelerated the cell cycle and promoted cell proliferation, but UTR-APA and CR-APA act via different molecular mechanisms. These results indicate that PAS editing with CRISPR/Cas9 provides a good method by which to study the biological function of APA.
引用
收藏
相关论文
共 50 条
  • [31] Regulation of Rb family proteins by Cdk6/Ccnd1 in growth plates
    Komori, Toshihisa
    CELL CYCLE, 2013, 12 (14) : 2161 - 2162
  • [32] Trps1 targets Ccnd1 to regulate mouse Leydig cell proliferation
    Sun, Jiandong
    Li, Hua
    Lv, Chengyu
    Draz, Eman
    Liu, Yue
    Lin, Zihang
    Hu, Weitao
    Mo, Kaien
    Lin, Jianmin
    Xu, Weiwei
    Wang, Shie
    ANDROLOGY, 2021, 9 (06) : 1923 - 1933
  • [33] Dlx5 promotes cancer progression through regulation of CCND1 in oral squamous cell carcinoma (OSCC)
    Zhang, Jianfei
    Wu, Jinyang
    Chen, Yang
    Zhang, Wenbin
    BIOCHEMISTRY AND CELL BIOLOGY, 2021, 99 (04) : 424 - 434
  • [34] Mantle cell lymphoma with a novel t(11;12)(q13;p11.2): a proposed alternative mechanism of CCND1 up-regulation
    Menke, Joshua R.
    Vasmatzis, George
    Murphy, Stephen
    Yang, Lin
    Menke, David M.
    Tun, Han W.
    King, Rebecca L.
    Smoley, Stephanie A.
    Ketterling, Rhett P.
    Sukov, William R.
    HUMAN PATHOLOGY, 2017, 64 : 207 - 212
  • [35] Alternative polyadenylation regulation: insights from sequential polyadenylation
    Tang, Peng
    Zhou, Yu
    TRANSCRIPTION-AUSTIN, 2022, 13 (4-5): : 89 - 95
  • [36] CDC42EP3 promotes glioma progression via regulation of CCND1
    Zhigang Yang
    Tao Xu
    Tao Xie
    Liangliang Yang
    Guiping Wang
    Yang Gao
    Gangming Xi
    Xiaobiao Zhang
    Cell Death & Disease, 13
  • [37] EXPRESSION OF THE CYCLIN-D1 (CCND1) GENE IN B-CELL LYMPHOMAS
    DEBOER, CJ
    LOYSON, S
    KLUIN, PM
    KLUINNELEMANS, JC
    VANKRIEKEN, JHJM
    SCHUURING, E
    BLOOD, 1994, 84 (10) : A450 - A450
  • [38] miR-1247-3p regulation of CCND1 affects chemoresistance in colorectal cancer
    Wang, Dequan
    Wang, Jielian
    Yao, Fei
    Xie, Zhufu
    Wu, Jianze
    Chen, Huiguang
    Wu, Qingming
    PLOS ONE, 2024, 19 (12):
  • [39] Heterogeneous abnormalities of CCND1 and RB1 in primary cutaneous T-cell lymphomas suggesting impaired cell cycle control in disease pathogenesis
    Mao, Xin
    Orchard, Guy
    Vonderheid, Eric C.
    Nowell, Peter C.
    Bagot, Martine
    Bensussan, Armand
    Russell-Jones, Robin
    Young, Bryan D.
    Whittaker, Sean J.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 (06) : 1388 - 1395
  • [40] Genetic alterations of CCND1 and EMSY in breast cancers
    Kirkegaard, T.
    Nielsen, K. V.
    Jensen, L. B.
    Campbell, F. M.
    Mueller, S.
    Tovey, S. M.
    Brown, S.
    Cooke, T. G.
    Bartlett, J. M. S.
    HISTOPATHOLOGY, 2008, 52 (06) : 698 - 705